Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
File TM, Goldberg L, Das A, Sweeney C, Saviski J, Gelone SP, Seltzer E, Paukner S, Wicha WW, Talbot GH, Gasink LB. File TM, et al. Among authors: goldberg l. Clin Infect Dis. 2019 Nov 13;69(11):1856-1867. doi: 10.1093/cid/ciz090. Clin Infect Dis. 2019. PMID: 30722059 Free PMC article. Clinical Trial.
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
Paukner S, Goldberg L, Alexander E, Das AF, Heinrich S, Patel P, Moran GJ, Sandrock C, File TM Jr, Vidal JE, Waites KB, Gelone SP, Schranz J. Paukner S, et al. Among authors: goldberg l. J Glob Antimicrob Resist. 2022 Jun;29:434-443. doi: 10.1016/j.jgar.2021.10.021. Epub 2021 Nov 14. J Glob Antimicrob Resist. 2022. PMID: 34788694 Free article. Clinical Trial.
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
Lodise TP, Colman S, Alexander E, Stein DS, Fitts D, Goldberg L, Schranz J. Lodise TP, et al. Among authors: goldberg l. Open Forum Infect Dis. 2020 Jun 3;7(6):ofaa209. doi: 10.1093/ofid/ofaa209. eCollection 2020 Jun. Open Forum Infect Dis. 2020. PMID: 32617376 Free PMC article.
Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
Lodise T, Colman S, Stein DS, Fitts D, Goldberg L, Alexander E, Scoble PJ, Schranz J. Lodise T, et al. Among authors: goldberg l. Open Forum Infect Dis. 2020 Apr 24;7(5):ofaa145. doi: 10.1093/ofid/ofaa145. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID: 32462049 Free PMC article.
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
File TM, Goldberg L, Das A, Sweeney C, Saviski J, Gelone SP, Seltzer E, Paukner S, Wicha WW, Talbot GH, Gasink LB. File TM, et al. Among authors: goldberg l. Clin Infect Dis. 2020 May 23;70(11):2459. doi: 10.1093/cid/ciz710. Clin Infect Dis. 2020. PMID: 31626688 Free PMC article. No abstract available.
Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
Jauregui LE, Babazadeh S, Seltzer E, Goldberg L, Krievins D, Frederick M, Krause D, Satilovs I, Endzinas Z, Breaux J, O'Riordan W. Jauregui LE, et al. Among authors: goldberg l. Clin Infect Dis. 2005 Nov 15;41(10):1407-15. doi: 10.1086/497271. Epub 2005 Oct 6. Clin Infect Dis. 2005. PMID: 16231250 Clinical Trial.
Atp1a2 and Kcnj9 are candidate genes underlying oxycodone behavioral sensitivity and withdrawal in C57BL/6 substrains.
Goldberg LR, Baskin BM, Adla Y, Beierle JA, Kelliher JC, Yao EJ, Kirkpatrick SL, Reed ER, Jenkins DF, Luong AM, Luttik KP, Scotellaro JA, Drescher TA, Crotts SB, Yazdani N, Ferris MT, Johnson WE, Mulligan MK, Bryant CD. Goldberg LR, et al. bioRxiv [Preprint]. 2024 Apr 17:2024.04.16.589731. doi: 10.1101/2024.04.16.589731. bioRxiv. 2024. PMID: 38798314 Free PMC article. Preprint.
1,849 results